Skip to main content

Long-Term Efficacy of Restricted Quantitative Superior Placement Technique in Total Hip Arthroplasty for Severe Developmental Dysplasia of the Hip: An 8- to 10-Year Follow-Up of a Prospective Randomized Controlled Trial

In brief

In severe hip dysplasia, cup placement up to 15 mm higher improved long-term hip scores

In a randomized trial of 44 hips with developmental dysplasia, restricted superior cup placement was linked to higher hip scores at 8 to 10 years than placement at the anatomic center; none of the 36 hips followed that long needed revision. Quality-of-life scores and complication rates did not differ significantly, and the small number of hips limits how firmly the results can guide practice.

Journal
Orthopaedic surgery (Q1)
Published
5 November 2026
Study design
Randomized controlled trial
Evidence level
Level 1, High (CEBM 1b)
Authors
Shuai Li, Zhijian Yang, Dong Jiang, Yu Xie, Xiaomin Lu, Xiaoyi Zhao, et al.
PMID
42988735
DOI
10.1111/os.70448

Why clinicians should know about it

  • Picked for Orthopedics and Sports Medicine (paper of the day, 8 November 2026): Randomized long-term comparison of acetabular placement in dysplasia arthroplasty

Abstract

OBJECTIVE: Total hip arthroplasty (THA) in patients with developmental dysplasia of the hip (DDH), particularly those with Crowe II or III dysplasia, is challenging because of abnormal acetabular morphology and deficient bone stock. This study aims to compare the long-term outcomes of true anatomic versus restricted quantitative superior placement of the acetabular component. METHODS: This prospective, patient- and assessor-blinded randomized controlled trial was conducted from August 1, 2013, to July 31, 2024. Forty-four hips were allocated 1:1 to true anatomic center placement or restricted quantitative superior placement. Restricted quantitative superior placement was defined as positioning the cup center no more than 15 mm superior to the true anatomic center. Harris Hip Score (HHS), 36-Item Short Form Health Survey (SF-36), complications, perioperative outcomes, and radiographic parameters were assessed. The mean final follow-up was 8.94 years. Independent-samples t-test, Mann-Whitney U test, Chi-square test, and Fisher's exact test were used for statistical analysis. RESULTS: No statistically significant between-group difference was observed in prosthetic complications. No revisions were recorded among the 36 hips that completed the 8-10-year follow-up. At the 8-10-year follow-up, the restricted quantitative superior placement group had a higher HHS than the true anatomic center group (93.70 ± 5.20 vs. 86.73 ± 11.62, p = 0.024); multiple imputation analysis showed a mean difference of 5.79 points (95% CI, 0.46-11.13; p = 0.034). Significant between-group differences were also observed at 2 and 7 years. SF-36 scores did not differ significantly between groups. Morselized bone grafting was required in 45.5% of the anatomic center group and 40.9% of the restricted quantitative superior center group. Structural grafting was used in 18.2% and 9.1%, respectively. Radiographic analysis showed higher center of rotation height and less limb lengthening in the restricted quantitative superior center group. CONCLUSIONS: Restricted quantitative superior placement within 15 mm above the true anatomic center was associated with higher long-term HHS, with no significant difference in prosthetic complications and no revisions recorded among the 36 hips that completed the 8-10-year follow-up. It may represent a potential reconstructive option for patients with DDH. TRIAL REGISTRATION: Chictr.org, ChiCTR-TRC-1404388; https://www.chictr.org.cn/showproj.html?proj=5182.

Abstract as published, via PubMed.

View on PubMedFull text at the publisherOpen in the app

For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.